Table 5. Summary of prospective and retrospective clinical studies .

AIRTRIP - Anakinra-Treatment of Recurrent Pericarditis, IRAP - International Registry of Anakinra for Pericarditis

Study	Year	Patient size	Drug Regimen	Result
Imazio et al. [18] (IRAP)	2020	224	100 mg/day	91% reduction in Emergency Department visits and 86% reduction in hospitalizations after six months on anakinra compared to prior treatment
Shaukat et al. [21]	2020	34	100 mg/day	Anakinra group had a higher rate of resolution of symptoms and in a shorter period of time in comparison to the traditional therapy group.
Brucato et al. [16]  (AIRTRIP)	2016	21	2 mg/kg/day Max:100 mg/day	Recurrence of pericarditis was significantly lower in the anakinra group compared to the placebo group.